Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Tuberculosis

Free Subscription Articles published in J Infect Retrieve available abstracts of 60 articles: HTML format Text format

Single Articles

October 2019
1. KARMAKAR M, Trauer JM, Ascher DB, Denholm JT, et al
   Hyper transmission of Beijing lineage Mycobacterium tuberculosis: Systematic review and Meta-analysis.
   J Infect. 2019 Oct 1. pii: S0163-4453(19)30287.
   PubMed     Text format     Abstract available
   
   
   September 2019
2. MANALAN K, Green N, Arnold A, Cooke GS, et al
   A cost comparison of amikacin therapy with bedaquiline, for drug-resistant tuberculosis in the UK.
   J Infect. 2019 Sep 21. pii: S0163-4453(19)30277.
   PubMed     Text format     Abstract available
   
   
   August 2019
3. SOTGIU G, Saderi L, Petruccioli E, Aliberti S, et al
   QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis.
   J Infect. 2019 Aug 29. pii: S0163-4453(19)30258.
   PubMed     Text format     Abstract available
   
   
   
4. LIU Z, Dong H, Wu B, Zhang M, et al
   Is rifampin resistance a reliable predictive marker of multidrug-resistant tuberculosis in China: A meta-analysis of findings.
   J Infect. 2019 Aug 7. pii: S0163-4453(19)30243.
   PubMed     Text format     Abstract available
   
   
   July 2019
5. MANNGO PM, Gutschmidt A, Snyders CI, Mutavhatsindi H, et al
   Prospective evaluation of host biomarkers other than interferon gamma in QuantiFERON Plus supernatants as candidates for the diagnosis of tuberculosis in symptomatic individuals.
   J Infect. 2019 Jul 15. pii: S0163-4453(19)30217.
   PubMed     Text format     Abstract available
   
   
   June 2019
6. SUN Q, Wang S, Dong W, Jiang G, et al
   Diagnostic value of Xpert MTB/RIF Ultra for osteoarticular tuberculosis.
   J Infect. 2019 Jun 14. pii: S0163-4453(19)30186.
   PubMed     Text format     Abstract available
   
   
   May 2019
7. ZHANG M, He JQ
   Is the analysis sufficient? Letter to the Editor concerning the study of Prof. Wang titled "Xpert MTB/RIF Ultra improved the diagnosis of paucibacillary tuberculosis: A prospective cohort study".
   J Infect. 2019 May 28. pii: S0163-4453(19)30164.
   PubMed     Text format    
   
   
   
8. XU P, Tang P, Song H, Zhao J, et al
   The Incremental Value of Bronchoalveolar Lavage for the Diagnosis of Pulmonary Tuberculosis in a High-Burden Urban Setting.
   J Infect. 2019 May 14. pii: S0163-4453(19)30153.
   PubMed     Text format     Abstract available
   
   
   April 2019
9. CHIACCHIO T, Petruccioli E, Vanini V, Cuzzi G, et al
   Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases.
   J Infect. 2019 Apr 11. pii: S0163-4453(19)30122.
   PubMed     Text format     Abstract available
   
   
   
10. CAO Y, Yu C, Wu Y
    Incidence rate of depression as an adverse effect of multidrug-resistant tuberculosis treatment.
    J Infect. 2019 Apr 9. pii: S0163-4453(19)30113.
    PubMed     Text format    
    
    
    March 2019
11. MAHOMED S, Padayatchi N, Singh J, Naidoo K, et al
    Precision Medicine in Resistant Tuberculosis: Treat the correct patient, at the correct time, with the correct drug.
    J Infect. 2019 Mar 5. pii: S0163-4453(19)30075.
    PubMed     Text format     Abstract available
    
    
    February 2019
12. WANG G, Wang S, Jiang G, Yang X, et al
    Xpert MTB/RIF Ultra improved the diagnosis of paucibacillary tuberculosis: a prospective cohort study.
    J Infect. 2019 Feb 20. pii: S0163-4453(19)30059.
    PubMed     Text format     Abstract available
    
    
    January 2019
13. ZHANG H, Xin H, Wang D, Pan S, et al
    Serial Testing of Mycobacterium Tuberculosis Infection in Chinese Village Doctors by QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube and T-SPOT.TB.
    J Infect. 2019 Jan 30. pii: S0163-4453(19)30030.
    PubMed     Text format     Abstract available
    
    
    
14. LEE MR, Chang CH, Chang LY, Chuang YC, et al
    CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status.
    J Infect. 2019 Jan 29. pii: S0163-4453(19)30028.
    PubMed     Text format     Abstract available
    
    
    
15. HAMBLION EL, Burkitt A, Lalor MK, Anderson LF, et al
    Public Health Outcome of Tuberculosis Cluster Investigations, England 2010-2013.
    J Infect. 2019 Jan 14. pii: S0163-4453(19)30004.
    PubMed     Text format     Abstract available
    
    
    December 2018
16. ZHAO HM, Du R, Li CL, Ji P, et al
    Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.
    J Infect. 2018 Dec 5. pii: S0163-4453(18)30354.
    PubMed     Text format     Abstract available
    
    
    
17. LUO J, Zhang M, Yan B, Li F, et al
    Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating among Mycobacterium tuberculosis infection.
    J Infect. 2018 Dec 5. pii: S0163-4453(18)30355.
    PubMed     Text format     Abstract available
    
    
    October 2018
18. PRADIPTA IS, Forsman LD, Bruchfeld J, Hak E, et al
    Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis.
    J Infect. 2018 Oct 16. pii: S0163-4453(18)30307.
    PubMed     Text format     Abstract available
    
    
    September 2018
19. SALI M, Buonsenso D, D'Alfonso P, De Maio F, et al
    Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children.
    J Infect. 2018 Sep 26. pii: S0163-4453(18)30284.
    PubMed     Text format     Abstract available
    
    
    August 2018
20. UHEL F, Corvaisier G, Poinsignon Y, Chirouze C, et al
    Mycobacterium tuberculosis prosthetic joint infections: a case series and literature review.
    J Infect. 2018 Aug 20. pii: S0163-4453(18)30253.
    PubMed     Text format     Abstract available
    
    
    
21. HU Y, Yang Q, Dong J, Sun L, et al
    Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs.
    J Infect. 2018 Aug 11. pii: S0163-4453(18)30251.
    PubMed     Text format     Abstract available
    
    
    
22. BORISOV SE, D'Ambrosio L, Centis R, Tiberi S, et al
    Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline -containing regimens and undergoing adjunctive surgery.
    J Infect. 2018 Aug 7. pii: S0163-4453(18)30246.
    PubMed     Text format     Abstract available
    
    
    July 2018
23. ALENE KA, Clements ACA, McBryde ES, Jaramillo E, et al
    Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis.
    J Infect. 2018 Jul 20. pii: S0163-4453(18)30221.
    PubMed     Text format     Abstract available
    
    
    
24. SABI I, Rachow A, Mapamba D, Clowes P, et al
    Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study.
    J Infect. 2018 Jul 20. pii: S0163-4453(18)30214.
    PubMed     Text format     Abstract available
    
    
    
25. KOWADA A
    Interferon-gamma release assay for tuberculosis screening of solid-organ transplant recipients is cost-effective.
    J Infect. 2018 Jul 12. pii: S0163-4453(18)30215.
    PubMed     Text format     Abstract available
    
    
    June 2018
26. GAO Y, Zhang Z, Deng J, Mansjo M, et al
    Multi-center evaluation of GenoType MTBDRsl line probe assay for rapid detection of pre-XDR and XDR Mycobacterium tuberculosis in China.
    J Infect. 2018 Jun 30. pii: S0163-4453(18)30192.
    PubMed     Text format     Abstract available
    
    
    
27. TO KW, Kam KM, Chan DPC, Yip WH, et al
    Application of GeneXpert on bronchoalveolar lavage samples in the clinical management of patients suspicious of tuberculosis in an intermediate-burden setting.
    J Infect. 2018 Jun 28. pii: S0163-4453(18)30189.
    PubMed     Text format     Abstract available
    
    
    
28. MORAN E, Baharani J, Dedicoat M, Robinson E, et al
    Renal failure and active tuberculosis in a high incidence UK city.
    J Infect. 2018 Jun 18. pii: S0163-4453(18)30179.
    PubMed     Text format     Abstract available
    
    
    May 2018
29. PT P, B M, Fgj C
    BCG vaccination protects against infection with Mycobacterium tuberculosis ascertained by tuberculin skin testing.
    J Infect. 2018 May 17. pii: S0163-4453(18)30127.
    PubMed     Text format     Abstract available
    
    
    
30. ANURADHA R, Munisankar S, Bhootra Y, Kumar NP, et al
    Malnutrition is associated with diminished baseline and mycobacterial antigen - stimulated chemokine responses in latent tuberculosis infection.
    J Infect. 2018 May 16. pii: S0163-4453(18)30143.
    PubMed     Text format     Abstract available
    
    
    
31. KIM JY, Park JH, Kim MC, Cha HH, et al
    Combined IFN-gamma and TNF-alpha release assay for differentiating active tuberculosis from latent tuberculosis infection.
    J Infect. 2018 May 7. pii: S0163-4453(18)30116.
    PubMed     Text format     Abstract available
    
    
    
32. ZHANG H, Xin H, Li X, Li H, et al
    Reversion of QuantiFERON-TB Gold In-Tube test in individuals with and without prophylactic treatment for latent tuberculosis infection: a Systematic Review and Meta-Analysis.
    J Infect. 2018 May 7. pii: S0163-4453(18)30112.
    PubMed     Text format     Abstract available
    
    
    
33. E BS, Magda E, YuRong Y, Guangyu G, et al
    Identification of a plasma microRNA profile in untreated pulmonary tuberculosis patients that is modulated by anti-mycobacterial therapy.
    J Infect. 2018 May 7. pii: S0163-4453(18)30122.
    PubMed     Text format     Abstract available
    
    
    April 2018
34. NGUYEN DTM, Graviss EA
    Development and validation of a prognostic score to predict tuberculosis mortality.
    J Infect. 2018 Apr 9. pii: S0163-4453(18)30062.
    PubMed     Text format     Abstract available
    
    
    January 2018
35. XU C, Pang Y, Li R, Ruan Y, et al
    Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China.
    J Infect. 2018 Jan 25. pii: S0163-4453(18)30025.
    PubMed     Text format     Abstract available
    
    
    November 2017
36. LIU Y, Li X, Liu W, Liu Y, et al
    IL-6 release of Rv0183 antigen-stimulated whole blood is a potential biomarker for active tuberculosis patients.
    J Infect. 2017 Nov 24. pii: S0163-4453(17)30376.
    PubMed     Text format     Abstract available
    
    
    October 2017
37. ROYCROFT E, O'Toole RF, Fitzgibbon MM, Montgomery L, et al
    Molecular epidemiology of multi- and extensively-drug-resistant Mycobacterium tuberculosis in Ireland, 2001-2014.
    J Infect. 2017 Oct 12. pii: S0163-4453(17)30315.
    PubMed     Text format     Abstract available
    
    
    September 2017
38. FRANCISCO NM, Fang YM, Ding L, Feng S, et al
    Diagnostic accuracy of a selected signature gene set that discriminates active pulmonary tuberculosis and other pulmonary diseases.
    J Infect. 2017 Sep 20. pii: S0163-4453(17)30304.
    PubMed     Text format     Abstract available
    
    
    
39. SHAH R, Nabiswa H, Okinda N, Revathi G, et al
    The Diagnostic Accuracy Of Determine Tb Lam Antigen In Detection Of Extra Pulmonary Tuberculosis (Eptb).
    J Infect. 2017 Sep 4. pii: S0163-4453(17)30268.
    PubMed     Text format    
    
    
    August 2017
40. PANG Y, Lu J, Huo F, Ma Y, et al
    Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China: a five-year review.
    J Infect. 2017 Aug 10. pii: S0163-4453(17)30262.
    PubMed     Text format     Abstract available
    
    
    
41. TEIXEIRA RC, Rodriguez M, Jimenez de Romero N, Bruins M, et al
    The potential of a portable, point-of-care electronic nose to diagnose tuberculosis.
    J Infect. 2017 Aug 10. pii: S0163-4453(17)30260.
    PubMed     Text format     Abstract available
    
    
    
42. RUFAI SB, Singh A, Singh J, Kumar P, et al
    Diagnostic usefulness of Xpert MTB/RIF assay for detection of tuberculous meningitis using cerebrospinal fluid.
    J Infect. 2017;75:125-131.
    PubMed     Text format     Abstract available
    
    
    July 2017
43. VILLAR-HERNANDEZ R, Latorre I, Minguez S, Diaz J, et al
    Use of IFN-gamma and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases.
    J Infect. 2017 Jul 24. pii: S0163-4453(17)30248.
    PubMed     Text format     Abstract available
    
    
    
44. HELLA J, Morrow C, Mhimbira F, Ginsberg S, et al
    Tuberculosis transmission in public locations in Tanzania: a novel approach to studying airborne disease transmission.
    J Infect. 2017 Jul 1. pii: S0163-4453(17)30227.
    PubMed     Text format     Abstract available
    
    
    June 2017
45. PEREZ-VELEZ CM, Roya-Pabon CL, Marais BJ
    A systematic approach to diagnosing intra-thoracic tuberculosis in children.
    J Infect. 2017;74 Suppl 1:S74-S83.
    PubMed     Text format     Abstract available
    
    
    
46. OUTHRED AC, Britton PN, Marais BJ
    Drug-Resistant tuberculosis - primary transmission and management.
    J Infect. 2017;74 Suppl 1:S128-S135.
    PubMed     Text format     Abstract available
    
    
    
47. PORMOHAMMAD A, Riahi SM, Nasiri MJ, Fallah F, et al
    Diagnostic test accuracy of adenosine deaminase for tuberculous meningitis: A systematic review and meta-analysis.
    J Infect. 2017;74:545-554.
    PubMed     Text format     Abstract available
    
    
    May 2017
48. CLIFFORD V, Tebruegge M, Zufferey C, Germano S, et al
    Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis.
    J Infect. 2017 May 5. pii: S0163-4453(17)30131.
    PubMed     Text format     Abstract available
    
    
    
49. JELJELI M, Guerin-El Khourouj V, Pommelet V, Hormi M, et al
    Cytokine/chemokine secretion for detecting tuberculosis in quantiferon supernatants from HIV+ and HIV- children.
    J Infect. 2017 May 3. pii: S0163-4453(17)30129.
    PubMed     Text format    
    
    
    
50. NOUHIN J, Pean P, Madec Y, Chevalier MF, et al
    Interleukin-1 receptor antagonist, a biomarker of response to anti-TB treatment in HIV/TB co-infected patients.
    J Infect. 2017;74:456-465.
    PubMed     Text format     Abstract available
    
    
    March 2017
51. SIMONSEN DF, Farkas DK, Horsburgh CR, Thomsen PR, et al
    Increased risk of active Tuberculosis after Cancer diagnosis.
    J Infect. 2017 Mar 30. pii: S0163-4453(17)30105.
    PubMed     Text format    
    
    
    
52. ARNOLD A, Cooke GS, Kon OM, Dedicoat M, et al
    Drug resistant TB: UK multicentre study (DRUMS): Treatment, management and outcomes in London and West Midlands 2008-2014.
    J Infect. 2017;74:260-271.
    PubMed     Text format     Abstract available
    
    
    February 2017
53. PARCELL BJ, Jarchow-MacDonald A, Seagar AL, Laurenson I, et al
    Three Year Evaluation of Xpert MTB/RIF in a Low Prevalence Tuberculosis Setting: a Scottish Perspective.
    J Infect. 2017 Feb 22. pii: S0163-4453(17)30054.
    PubMed     Text format     Abstract available
    
    
    January 2017
54. PEGORIE M, Denning DW, Welfare W
    Estimating the burden of invasive and serious fungal disease in the United Kingdom.
    J Infect. 2017;74:60-71.
    PubMed     Text format     Abstract available
    
    
    December 2016
55. ZETOLA NM, Modongo C, Matsiri O, Tamuhla T, et al
    Diagnosis of pulmonary tuberculosis and assessment of treatment response through analyses of volatile compound patterns in exhaled breath samples.
    J Infect. 2016 Dec 22. pii: S0163-4453(16)30336.
    PubMed     Text format     Abstract available
    
    
    
56. WYPLOSZ B, Mougari F, Al Rawi M, Baillon C, et al
    Visualizing viable Mycobacterium tuberculosis in sputum to monitor isolation measures.
    J Infect. 2016 Dec 7. pii: S0163-4453(16)30313.
    PubMed     Text format    
    
    
    November 2016
57. WON EJ, Choi JH, Cho YN, Jin HM, et al
    Biomarkers for Discrimination between Latent Tuberculosis Infection and Active Tuberculosis Disease.
    J Infect. 2016 Nov 18. pii: S0163-4453(16)30306.
    PubMed     Text format     Abstract available
    
    
    
58. OH J, Choi R, Park HD, Lee H, et al
    Evaluation of vitamin status in patients with pulmonary tuberculosis.
    J Infect. 2016 Nov 10. pii: S0163-4453(16)30280.
    PubMed     Text format     Abstract available
    
    
    October 2016
59. KUMAR NP, Moideen K, Sivakumar S, Menon PA, et al
    Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.
    J Infect. 2016 Oct 4. pii: S0163-4453(16)30246.
    PubMed     Text format     Abstract available
    
    
    April 2016
60. PARK KH, Lee MS, Kim SM, Park SJ, et al
    Diagnostic usefulness of T-cell based assays for tuberculous meningitis in HIV-uninfected patients.
    J Infect. 2016;72:486-97.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: